Results 1 to 10 of about 27,718 (188)

Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators [PDF]

Journal of Arrhythmia
Background Battery longevity in high‐voltage devices (HVDs), specifically implantable cardioverter‐defibrillators (ICDs) and cardiac resynchronization therapy‐defibrillators (CRT‐Ds), is critical for reducing the frequency of generator replacements ...
Kotaro Nishino, Taro Temma, Masaya Watanabe, Motoki Nakao, Masahiro Kawasaki, Kintaro Shimano, Kei Kawakami, Shota Saito, Jiro Koya, Daishiro Tatsuta, Hiroyuki Natsui, Takuya Koizumi, Takahide Kadosaka, Taro Koya, Kiwamu Kamiya, Toshiyuki Nagai, Toshihisa Anzai   +16 more
doaj   +2 more sources

Data deluge from remote monitoring of cardiac implantable electronic devices and importance of clinical stratification

Heart Rhythm O2, 2023
Background: Remote monitoring (RM) has been accepted as a standard of care for follow-up of patients with cardiac implantable electronic devices (CIEDs). However, the resulting data deluge poses major challenge to device clinics.
Danish Bawa, MD, Rajesh Kabra, MD, FHRS, Adnan Ahmed, MD, Shanti Bansal, MD, FHRS, Douglas Darden, MD, FHRS, Naga Venkata K. Pothineni, MD, FHRS, Rakesh Gopinathannair, MD, FHRS, Dhanunjaya Lakkireddy, MD, FHRS   +7 more
doaj   +1 more source

Comparison of Anxiety and Depression Symptoms in Individuals According to their Sex, Type of Cardiac Device, and Diagnosis of Chagas Disease

Brazilian Journal of Cardiovascular Surgery, 2022
Introduction: Implantable cardiac pacemakers or cardioverter defibrillators are alternatives for the treatment of arrhythmias, however, their use has caused changes in the emotional state of patients.
Carina Aparecida Marosti Dessotte, Elisa Maia de Oliveira Grotti, Isabelle Brigliadori Ignácio, Paolla Algarte Fernandes, Suellen Rodrigues de Oliveira Maier, Lidia Aparecida Rossi, Rosana Aparecida Spadoti Dantas   +6 more
doaj   +1 more source

Inappropriate ICD Shock as a Result of TASER Discharge

JACC: Case Reports, 2020
Conducted energy weapon (commonly known as TASER) discharge in patients with implantable cardioverter-defibrillators is known to cause electromagnetic interference and inappropriate ventricular fibrillation sensing without delivery of implantable ...
Chirag R. Barbhaiya, MD, Craig Moskowitz, MD, Harish Duraiswami, CCDS, Lior Jankelson, MD, PhD, Robert J. Knotts, MD, Scott Bernstein, MD, David Park, MD, PhD, Douglas Holmes, MD, Anthony Aizer, MD, MS, Larry A. Chinitz, MD   +9 more
doaj   +1 more source

Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator [PDF]

, 2003
Several studies have reported improved survival rates thanks to the use of an implantable cardioverter defibrillator (ICD) in the treatment of patients with life-threatening arrhythmia.
Brugemann, J., Coster, J., de Greef, M., van der Schans, C., van Gelder, I., van Ittersum, M.   +5 more
core   +11 more sources

Implantable cardioverter defibrillators [PDF]

Clinical Medicine, 2007
Sudden cardiac death occurs in 70,000-100,000 people annually in the UK, mostly in people with pre-existing heart disease but in 20% it is the first presentation Previous myocardial infarction (Ml) and significant left ventricular dysfunction are associated with a high rate of sudden cardiac death Implantable defibrillators are recommended in the ...
Stuart, Harris, Mehul, Dhinoja
openaire   +2 more sources

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundInadvertent damage to leads for transvenous pacemakers, implantable cardioverter‐defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator‐replacement procedures.
Christine I. Nichols, Joshua G. Vose, Suneet Mittal   +2 more
doaj   +1 more source

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs

Sensors, 2021
The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to ...
Dominic A. M. J. Theuns, Sumant P. Radhoe, Jasper J. Brugts   +2 more
doaj   +1 more source

Defibrillation Testing During Defibrillator Implantation [PDF]

Arrhythmia & Electrophysiology Review, 2012
Implantable cardioverter defibrillators (ICDs) terminate ventricular tachycardia (VT) and ventricular fibrillation (VF) with high efficacy. ICDs improve mortality in patients after survived sudden cardiac death (SCD) and in patients at high risk of dying suddenly.
openaire   +2 more sources

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)

Вестник анестезиологии и реаниматологии, 2018
The frequency of sudden cardiac death remains still high, globally every year 3 mln. people suddenly die. During last thirty years it has been possible to prevent sudden cardiac death by using implantable cardioverter-defibrillators.
N. V. Melnik
doaj   +1 more source